Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 10Genitourinary 6Gastrointestinal 6Thoracic 5Breast 5Gynecologic 4Sarcoma 1Other hematologic neoplasm 1Other 1Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hematologic Neoplasms 4Neoplasms 2Lymphoma, Non-Hodgkin 2Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia 1

Interventions

Leucovorin 4venetoclax 3Specimen Handling 3Fluorouracil 3Doxorubicin 3Cytarabine 3Cyclophosphamide 3Bevacizumab 3trametinib 2pembrolizumab 2dabrafenib 2Taxes 2Sorafenib 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Irinotecan 2Interleukin-2 2Gemcitabine 2Daunorubicin 2Carboplatin 2Bortezomib 2Biopsy 2Azacitidine 2Albumin-Bound Paclitaxel 2vactosertib 1temsirolimus 1ruxolitinib 1romidepsin 1regorafenib 1ponatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × atezolizumab × Other hematologic neoplasm × Clear all
NCT02862275 2026-05-13

Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
40 enrolled
Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡